NCT07740642Not yet recruiting
A Comparative Usability Study of Two Total Body Skin Imaging Systems
A Comparative Usability Study of Two Total Body Skin Imaging Systems: Vectra (3D Total Body Photography With Manual Dermoscopy) Versus Deviskan (Total Body Photography With Automated Non-Contact Dermoscopy)
Source: ClinicalTrials.gov · Last updated 3 Aug 2026
Brief summary (registry, in English)
This study aims to generate evidence on patient and dermatologist perspectives regarding two total body photography systems. Patient and clinician preferences represent key factors in healthcare decision-making. The investigation will also provide data on the time efficiency of each system in a real-world setting.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 20 Jul 2026
- Start date
- 3 Aug 2026
- Primary completion date
- 30 Sept 2026
- Lead sponsor
- University Hospital, Basel, Switzerland
- Diseases
- Melanoma
- NCT number
- NCT07740642
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 3 Aug 2026 to the primary completion date, 30 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Inability to follow the procedures of the investigation, including inability to follow on-screen instructions or to read (e.g. due to visual impairment or cognitive impairment)
- Active skin conditions that may impact the performance of TBP systems or skin cancer screenings
- Cardiac pacemaker
Other
- Lack of informed consent
- Immobility. (Patients must be able to stand without support for 30 minutes.)
- Vulnerable Subjects
- Pregnant women (self reported, no pregnancy test planned)
- Height below 150 cm or above 195 cm
- Severe Claustrophobia
Who the study is looking for
- Age ≥ 18 years
- Signed informed consent by the participant
- Sufficient proficiency in German
- At least one of the following risk criteria for melanoma:
- Previous melanoma (including in situ)
- Suspected melanoma
- ≥ 100 common naevi
- ≥ 5 dysplastic naevi
- dysplastic naevus syndrome
- Known CDKN2A mutation
- Strong family history for melanoma (≥ first- and/or second-degree relatives)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Basel Coordinator of this site? Confirm its status | Basel | Switzerland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.